Bryn Mawr Trust Advisors LLC Acquires New Shares in HCA Healthcare, Inc. $HCA

Posted by Geri Gentry on Jul 15th, 2026

Bryn Mawr Trust Advisors LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,598 shares of the company’s stock, valued at approximately $756,000.

Other large investors also recently modified their holdings of the company. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $29,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth $31,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare during the third quarter valued at $33,000. Finally, Cedar Mountain Advisors LLC bought a new position in HCA Healthcare in the 1st quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

Positive Sentiment: HCA said preliminary second-quarter revenue came in above Wall Street expectations, suggesting demand and patient volumes remained solid enough to support top-line growth. Reuters: HCA reports preliminary quarterly revenue above expectations
Neutral Sentiment: KeyCorp lowered its price target to $475 from $510 but kept an overweight rating, while Wells Fargo trimmed its target to $428 and maintained an equal weight rating, signaling some caution but not a full bearish call. Benzinga: Analyst updates on HCA Healthcare
Negative Sentiment: HCA reduced its full-year EPS guidance to 28.7 to 30.5, below consensus, indicating margin pressure and a softer profit outlook for the rest of the year.
Negative Sentiment: Management cited payer mix shifts tied to health insurance exchanges, along with rising uninsured patients and declining surgeries, as factors squeezing quarterly earnings and hurting expectations. WSJ: HCA Healthcare shares drop after quarterly earnings squeezed by payer mix shifts
Negative Sentiment: Barron’s reported that the stock fell after the company lowered its outlook, reinforcing investor concern that the strong revenue trend may not translate into comparable profit growth. Barrons: HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook

HCA Healthcare Stock Down 6.7%

Shares of HCA Healthcare stock opened at $364.46 on Wednesday. The firm has a market cap of $80.85 billion, a PE ratio of 12.53, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12. The company’s fifty day simple moving average is $395.39 and its two-hundred day simple moving average is $458.95. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the prior year, the company posted $6.45 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is 10.73%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Oppenheimer cut their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Royal Bank Of Canada reduced their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Wells Fargo & Company dropped their price target on HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating for the company in a research note on Monday. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $491.77.

View Our Latest Analysis on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.